Dr. Michael Tamilia is not included in the author byline. He should be listed as the third author and affiliated with Lady Davis Institute for Medical Research-Jewish General Hospital; Montreal, QC, Canada and Division of Endocrinology, Jewish General Hospital; Montreal, QC, Canada. The contributions of this author are as follows: Dr. Tamilia was involved in the very early process of the work describe in the paper, in both discussions and experimental design.
Citation: Dotan I, Roche PJR, Tamilia M, Paliouras M, Mitmaker EJ, Trifiro MA (2016) Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells. PLoS ONE 11(6): e0158022. https://doi.org/10.1371/journal.pone.0158022
Published: June 16, 2016
Copyright: © 2016 Dotan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.